Explore

Companies

Drugs

About·Data Management·Terms·Privacy

Stay informed

© 2026 VivoSeq. All rights reserved.

Trtl-913

TTortugas Neuroscience, Inc.

0

Indications

1

Total Trials

1

Active Trials

0

Competitors

Timeline

Expected Milestones

Q3 2027

Phase 2Recruiting

Tinnitus

NCT07777549

Clinical

Trials by Indication[1]

Tinnitus1 trial

A Phase 2a, Randomized, Placebo-Controlled, Multiple Ascending Dose Study to Evaluate the Safety, Tolerability, and Pharmacokinetics of TRTL-913 in Healthy Adult Volunteers Under Fed Conditions (Part A), and an Open-Label Multiple Ascending Dose Study to Evaluate the Safety, Tolerability, and Efficacy in Adults With Tinnitus (Part B)

Recruiting·TTortugas Neuroscience, Inc.·Phase 2·NCT07777549·100 enrolled

Sources

References

[1]
ClinicalTrials.gov — 1 trial record for Trtl-913. U.S. National Library of Medicine, National Institutes of Health.
[2]
SEC EDGAR — Tortugas Neuroscience, Inc. company filings. U.S. Securities and Exchange Commission.

Details

Drug Info

Quick Facts

Company: TTortugas Neuroscience, Inc.

Related News